BC_(369)治疗多发性骨髓瘤的临床研究

The Clinic Experiment of BC_(369)on Treating Multiple Myelome

作者采用生物制剂BC369（Biolgicals369）对14例多发性骨髓瘤（MultinleMyeloma，MM）进行治疗。临床资料统计：完全缓解（CR）4例，部分缓解（PR）3例，总有效（CR＋PR）率为50％（7／14）；完全缓解（CR）病例数占总有效率（CR＋PR）病例数的57．1％（4／7）。结果提示BC369对多发性骨髓瘤（MM）有较好的治疗作用。

14 Cases of multiple myeloma were treated by Biologicals 369. The results showed: Complete response for 3 cases; partial response for 3 cases; Assemble effective rate is 50%; Omplete response is 57. 1% of assemble effective cases. It is Suggestted that BC369 is effective on multiple myeloma.